While anaplastic lymphoma kinase (ALK) gene fusion was seen in large-cell lymphomas, its fusion with the promoter gene, echinoderm microtubule-associated protein-like 4 (EML4), was first discovered in 2007 in NSCLC as an oncogenic driver alteration [118,119]. This evidence concerns the gene ALK and non-small cell lung carcinoma.